跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISTA Agonist
首页
药物
VISTA Agonist
VISTA Agonist
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-human VISTA antibodies and use thereof
US 11525000 B2
申请人: IMMUNEXT INC
优先权: 2017
US
11 件公开
Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists
US 10370455 B2
申请人: IMMUNEXT INC
优先权: 2014
CN
US
2 件公开
Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
US 11951157 B2
申请人: UNIV ZUERICH
优先权: 2019
US
2 件公开
ANTI-CD40 ANTIBODIES IN COMBINATION AND METHODS OF USE
CN 110114089 A
申请人: APEXIGEN INC
优先权: 2016
CN
Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy
US 11649285 B2
申请人: BIO TECHNE CORP
优先权: 2017
US
Medical application of VISTA micromolecule agonist and drug composition of agonist
CN 109893530 A
申请人: UNIV CHINA PHARMA
优先权: 2018
CN
Use of inosine for cancer immunotherapy
US 10736913 B1
申请人: IMMUNOSPARKLE BIOSCIENCE LLC
优先权: 2020
US
VISTA agonists for treatment/prevention of ischemic and/or reperfusion injury
CN 116600826 A
申请人: DARTMOUTH COLLEGE
优先权: 2020
CN
VISTA AGONISTS AND RELATED COMPOSITIONS AND METHODS
US 20240293499 A1
申请人: SUNNYBROOK RES INST
优先权: 2022
US
Medical application of imatinib as VISTA agonist
CN 115844893 A
申请人: UNIV CHINA PHARMA
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈